Robinson James A. Jr.

CIK 00017342956 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001734295

Recent Transactions

37 trades

Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (right to buy)
2035-01-10+30,870→ 30,870 total
Exercise/Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Common Stock
2026-01-10+3,430→ 3,430 total
Exercise/Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Restricted Stock Units
2026-01-10−3,430→ 0 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
ordinary shares
2025-11-26+2,000→ 2,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Unit
2025-11-26−2,000→ 6,000 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2025-08-26+10,000→ 10,000 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Unit
2025-08-26+8,000→ 8,000 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Restricted Stock Units
2025-01-10+3,430→ 3,430 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2024-08-06+10,000→ 10,000 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (Right to Buy)
2023-10-02$1.55/sh+150,437→ 150,437 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2023-09-07+10,000→ 10,000 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2023-07-25+20,000→ 20,000 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2023-07-25+20,000→ 20,000 total
Disposition to Issuer
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2022-11-30−25,000→ 0 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2021-11-30+25,000→ 25,000 total
Disposition to Issuer
Urovant Sciences Ltd.
Common Shares
2021-03-29−8,385→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2021-03-29−50,000→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2021-03-29−25,000→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Stock Appreciation Right (Right to Buy)
2021-03-29−845,732→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−12,500→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−46,907→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Common Stock
2021-03-19−23,453→ 0 total
Tax Payment
Urovant Sciences Ltd.
Common Shares
2021-01-10$16.11/sh−4,095→ 8,385 total
Award
Neos Therapeutics, Inc.
Common Stock
2020-06-10+23,453→ 23,453 total
Award
Urovant Sciences Ltd.
Stock Appreciation Right (Right to Buy)
2020-03-23+845,732→ 845,732 total
Award
Urovant Sciences Ltd.
Common Shares
2020-01-10+12,480→ 12,480 total
Award
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2019-07-09+25,000→ 25,000 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-13+46,907→ 46,907 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2019-04-04−6,250→ 18,750 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2019-04-04+6,250→ 6,250 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2019-04-04$35.89/sh−1,838→ 4,412 total
Award
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2019-03-01+50,000→ 50,000 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2019-02-21+40,400→ 40,400 total
Award
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2019-02-21+157,000→ 157,000 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-29+12,500→ 12,500 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2018-04-04+25,000→ 25,000 total
Award
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2018-04-04$44.16/sh+140,000→ 140,000 total

Robinson James A. Jr.

Recent Transactions

Companies

Recent Filings

Address